Bespalov AY[au] - Search Results

Year	Number of Results
1996	1
1998	2
1999	6
2000	10
2001	3
2002	2
2003	2
2004	7
2005	7
2006	6
2007	4
2008	2
2009	1
2010	4
2015	1
2016	2
2017	1
2018	2
2019	1
2022	0

1

Antidepressant treatment in anxiety disorders.

Bespalov AY, van Gaalen MM, Gross G. Bespalov AY, et al. Curr Top Behav Neurosci. 2010;2:361-90. doi: 10.1007/7854_2009_3. Curr Top Behav Neurosci. 2010. PMID: 21309117 Review.

2

Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain?

Marek GJ, Behl B, Bespalov AY, Gross G, Lee Y, Schoemaker H. Marek GJ, et al. Among authors: bespalov ay. Mol Pharmacol. 2010 Mar;77(3):317-26. doi: 10.1124/mol.109.059865. Epub 2009 Nov 23. Mol Pharmacol. 2010. PMID: 19933774 Review.

3

mGlu1 receptor as a drug target for treatment of substance use disorders: time to gather stones together?

Dravolina OA, Zvartau E, Danysz W, Bespalov AY. Dravolina OA, et al. Among authors: bespalov ay. Psychopharmacology (Berl). 2017 May;234(9-10):1333-1345. doi: 10.1007/s00213-017-4581-1. Epub 2017 Mar 11. Psychopharmacology (Berl). 2017. PMID: 28285325 Review.

4

Activation of trace amine-associated receptor 1 attenuates schedule-induced polydipsia in rats.

Sukhanov I, Dorotenko A, Dolgorukova A, Hoener MC, Gainetdinov RR, Bespalov AY. Sukhanov I, et al. Among authors: bespalov ay. Neuropharmacology. 2019 Jan;144:184-192. doi: 10.1016/j.neuropharm.2018.10.034. Epub 2018 Oct 24. Neuropharmacology. 2019. PMID: 30366004

5

Opioid-NMDA receptor interactions may clarify conditioned (associative) components of opioid analgesic tolerance.

Bespalov AY, Zvartau EE, Beardsley PM. Bespalov AY, et al. Neurosci Biobehav Rev. 2001 Jun;25(4):343-53. doi: 10.1016/s0149-7634(01)00018-5. Neurosci Biobehav Rev. 2001. PMID: 11445139 Review.

6

Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders.

Bisaga A, Popik P, Bespalov AY, Danysz W. Bisaga A, et al. Among authors: bespalov ay. Expert Opin Investig Drugs. 2000 Oct;9(10):2233-48. doi: 10.1517/13543784.9.10.2233. Expert Opin Investig Drugs. 2000. PMID: 11060803 Review.

7

Agonist and antagonist effects of cytisine in vivo.

Radchenko EV, Dravolina OA, Bespalov AY. Radchenko EV, et al. Among authors: bespalov ay. Neuropharmacology. 2015 Aug;95:206-14. doi: 10.1016/j.neuropharm.2015.03.019. Epub 2015 Mar 31. Neuropharmacology. 2015. PMID: 25839895

8

Morphine-induced Straub tail reaction in mice treated with serotonergic compounds.

Belozertseva IV, Dravolina OA, Tur MA, Semina MG, Zvartau EE, Bespalov AY. Belozertseva IV, et al. Among authors: bespalov ay. Eur J Pharmacol. 2016 Nov 15;791:1-7. doi: 10.1016/j.ejphar.2016.08.014. Epub 2016 Aug 24. Eur J Pharmacol. 2016. PMID: 27565217

9

Enhanced brain penetration of hexamethonium in complexes with derivatives of fullerene C60.

Piotrovskiy LB, Litasova EV, Dumpis MA, Nikolaev DN, Yakovleva EE, Dravolina OA, Bespalov AY. Piotrovskiy LB, et al. Among authors: bespalov ay. Dokl Biochem Biophys. 2016 May;468(1):173-5. doi: 10.1134/S1607672916030030. Epub 2016 Jul 15. Dokl Biochem Biophys. 2016. PMID: 27417712

10

Efficacy and side effects of baclofen and the novel GABA_B receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction.

Vengeliene V, Takahashi TT, Dravolina OA, Belozertseva I, Zvartau E, Bespalov AY, Spanagel R. Vengeliene V, et al. Among authors: bespalov ay. Psychopharmacology (Berl). 2018 Jul;235(7):1955-1965. doi: 10.1007/s00213-018-4893-9. Epub 2018 Apr 12. Psychopharmacology (Berl). 2018. PMID: 29651507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results